Arabic Arabic English English French French German German
dark

Rocket Pharmaceuticals Highlights Anticipated 2022 Milestones Across Lentiviral and AAV Gene Therapy Clinical Programs

Rocket Pharmaceuticals, Inc. today shares expected milestones for 2022, which were discussed yesterday during the Company’s virtual presentation at the 40th Annual J.P. Morgan Healthcare Conference. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Ketamine and psychological therapy helped severe alcoholics abstain for longer in trial

Next Post

New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities

Related Posts
Total
0
Share